AstraZeneca investors press for talks after it spurns Pfizer again
British pharma giant rejects increased £50-a-share offer and refuses to meet its rival
Major investors in the pharmaceuticals giant AstraZeneca have urged the company to start negotiating with its US rival Pfizer after it rejected a sweetened £63bn takeover bid.
Although the assurances on investment helped to soothe political concerns over the £50-per-share bid, the AstraZeneca board yesterday said it had “no hesitation” in rejecting the offer, up 7 per cent from the original £46.61 move, and declared it would not even engage in talks.
AstraZeneca’s decision came after a hastily convened board meeting in London yesterday. The British company said too much of Pfizer’s offer consisted of shares rather than cash, and criticised the fact that the Viagra maker’s rationale for the deal was based upon tax savings. However, one top five shareholder told The Independent: “This is a serious enough offer for AstraZeneca to sit down and talk. We’re disappointed with the rejection but do agree that the bid is too low – the price needs to be higher.”
Another investor said: “Yes, the bid is too low but the rejection was too swift. The first obligation of the board is to shareholders. There should have been more of a discussion before such a fundamental decision was made.”
The influential Institute of Directors also warned MPs against intervening on political grounds, insisting that the takeovers are “primarily a matter for boards and shareholders to determine, not government”.
Robin Barker, the director of corporate governance at the IoD, added: “The board of AstraZeneca has so far rejected the bid, and they should continue to be sceptical about whether a tax-driven strategy makes the takeover in the long-term interest of the company.”
Read more: The town that Pfizer built up – and knocked down
Pfizer AstraZeneca takeover: Insider warns that acquisition could be ‘devastating’ for research
Sources close to the negotiations now expect Pfizer to come back with a higher offer as soon as next week. AstraZeneca is expected to meet with key investors over the next few days.
Pfizer’s chief executive Ian Read had attempted to soothe political concerns about the impact on Britain’s skilled workforce in a letter to the Prime Minister.
He also piled the pressure on Astra’s board to set up discussions, with the clipped comment: “Although we would have liked more time to meet privately to discuss our latest proposal, I believe that our revised terms are sufficient for you to agree to meet with us.”
Mr Read told David Cameron of the virtues of the “golden triangle”of Oxford, Cambridge and London, and pledged to complete AstraZeneca’s planned £300m Cambridge campus as well as employing at least a fifth of the combined company’s total research and development workforce in the UK. Pfizer spent only about 10 per cent of its revenues last year on research and development versus Astra’s 16 per cent spend, and its record of takeovers is one of heavy job cuts.
Yesterday, Pfizer committed itself to offering at least two AstraZeneca board members a place on the new company’s non-executive committee. It also agreed to hold board meetings in the UK.
In the latest bid, the cash element has been raised to 32 per cent from 30 per cent. Astra shares closed down 7p at 4,808p.
- 1 Russell Brand accuses FOX News anchor Sean Hannity of terrorism after aggressive Israel-Gaza debate
- 2 Disney heiress Abigail disowns her share of family profits in West Bank company
- 3 The secret report that helps Israel hide facts
- 4 Israel's propaganda machine is finally starting to misfire
- 5 'Hello mum, this is going to be hard for you to read ...'
Sally Farmiloe dead: Howards' Way actress, and former mistress of Jeffrey Archer, dies aged 60
Russell Brand accuses FOX News anchor Sean Hannity of terrorism after aggressive Israel-Gaza debate
Pope Francis issues top 10 tips for happiness – including don’t try to convert other people
Sabina Altynbekova, the girl branded 'too good looking' for volleyball, says social media obsession with her is a 'bit much'
Justin Bieber posts Instagram photo of Orlando Bloom crying after Ibiza fight 'over Miranda Kerr'
The secret report that helps Israel hide facts
Land for gas: Merkel and Putin discussed secret deal could end Ukraine crisis
Woman and two children killed by mob in riots over 'blasphemous' Facebook post in Pakistan
A day in the life of Vladimir Putin: The dictator in his labyrinth
Putin is 'thuggish, dishonest and reckless', says British ambassador to US
Richard Dawkins tweets: 'Date rape is bad, stranger rape is worse'
- < Previous
- Next >
iJobs Money & Business
£20000 - £24000 per annum: Harrington Starr: A leading provider of web based m...
£28000 - £32000 per annum: Ashdown Group: Secretary (Sales Team Support) - Mat...
Competitive (DOE): Guru Careers: We are looking for an Assistant Management Ac...
£600 - £700 per day + competitive: Orgtel: Senior Investment Accounting Change...